Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN

Stegelmann F, Wille K, Busen H, Fuchs C, Schauer S, Sadjadian P, Becker T, Kolatzki V, Döhner H, Stadler R, Döhner K, et al. (2020)
Leukemia.

Zeitschriftenaufsatz | E-Veröff. vor dem Druck | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Stegelmann, Frank; Wille, Kai; Busen, HannahUniBi ; Fuchs, ChristianeUniBi ; Schauer, Stefanie; Sadjadian, Parvis; Becker, Tatjana; Kolatzki, Vera; Döhner, Hartmut; Stadler, Rudolf; Döhner, Konstanze; Griesshammer, Martin
Alle
Stichworte
Anesthesiology and Pain Medicine; Cancer Research; Hematology
Erscheinungsjahr
2020
Zeitschriftentitel
Leukemia
ISSN
0887-6924
eISSN
1476-5551
Page URI
https://pub.uni-bielefeld.de/record/2944734

Zitieren

Stegelmann F, Wille K, Busen H, et al. Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia. 2020.
Stegelmann, F., Wille, K., Busen, H., Fuchs, C., Schauer, S., Sadjadian, P., Becker, T., et al. (2020). Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia. doi:10.1038/s41375-020-0945-3
Stegelmann, F., Wille, K., Busen, H., Fuchs, C., Schauer, S., Sadjadian, P., Becker, T., Kolatzki, V., Döhner, H., Stadler, R., et al. (2020). Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia.
Stegelmann, F., et al., 2020. Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia.
F. Stegelmann, et al., “Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN”, Leukemia, 2020.
Stegelmann, F., Wille, K., Busen, H., Fuchs, C., Schauer, S., Sadjadian, P., Becker, T., Kolatzki, V., Döhner, H., Stadler, R., Döhner, K., Griesshammer, M.: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia. (2020).
Stegelmann, Frank, Wille, Kai, Busen, Hannah, Fuchs, Christiane, Schauer, Stefanie, Sadjadian, Parvis, Becker, Tatjana, Kolatzki, Vera, Döhner, Hartmut, Stadler, Rudolf, Döhner, Konstanze, and Griesshammer, Martin. “Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN”. Leukemia (2020).

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 32616864
PubMed | Europe PMC

Suchen in

Google Scholar